Westlake Therapeutics
西湖生物医药
Westlake Therapeutics
Biotech/Healthcare
Founded in Hangzhou’s Xihu District in 2019, Westlake Therapeutics was the first commercialization project based on independently developed research from Westlake University following the university’s establishment. The company focuses on developing innovative red blood cell therapies.
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.